Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Current Opinion in Oncology|February 24, 2005
Bone marrow transplantation for lymphoma CR1Corrado Tarella, Alessandro M Gianni
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantationLiliana Devizzi, Anna Guidetti, Corrado Tarella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cellsPaolo Corradini, Anna Dodero, Francesco Zallio, et al.
Cancer|August 28, 2003
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3Alessandra Cuttica, Francesco Zallio, Marco Ladetto, et al.
Contributions to Nephrology|December 18, 2004
Intensive chemotherapy in patients with lymphoma. Management of the risk of hyperuricemiaCorrado Tarella, Davide Bono, Manuela Zanni, et al.
Expert Review of Hematology|April 25, 2022
Advances in therapeutic strategies for primary CNS B-cell lymphomasSafaa Ramadan, Tommaso Radice, Ahmed Ismail, et al.
Blood|March 29, 2003
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen)Alessandro M Gianni, Michele Magni, Maurizio Martelli, et al.
American Journal of Hematology|July 27, 2007
Treatment options in skeletal localizations of hairy cell leukemia: a systematic review on the role of radiation therapyAndrea R Filippi, Pierfrancesco Franco, Carlo Marinone, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphomaMarco Ladetto, Michele Magni, Gloria Pagliano, et al.
Cancer|May 14, 2011
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemiaAnna Guidetti, Carmelo Carlo-Stella, Marco Ruella, et al.
Pageof 16